TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35217236

Group type: EXPERIMENTAL
Intervention: Sitagliptin/metformin (sitaformin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33091433

Group type: EXPERIMENTAL
Intervention: SYN023 (0.3 mg/kg) alone
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: SYN023 (0.3 mg/kg) in combination with rabies vaccine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: SYN023 (0.3 mg/kg)
Number of subjects: 32
Study: 33001673

Group type: EXPERIMENTAL
Intervention: Anticonflict intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard methods
Number of subjects: 0
Study: 34419285

Group type: EXPERIMENTAL
Intervention: Tivozanib 1.5 mg orally once daily for 21 days in a 28-day cycle
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Tivozanib
Number of subjects: 30
Study: 32361963

Group type: EXPERIMENTAL
Intervention: Virtual reality breathing exercises with respiratory biofeedback
Number of subjects: 72

Group type: COMPARATOR
Intervention: Breathing exercises without respiratory biofeedback
Number of subjects: 72
Study: 34601705

Group type: EXPERIMENTAL
Intervention: Percutaneous tibial nerve stimulation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 50
Study: 32213454

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral psychotherapy (individual and group therapy), mean duration: 64.5 days
Number of subjects: 80
Study: 35271808

Group type: EXPERIMENTAL
Intervention: PRBC-LyoPlas
Number of subjects: 432

Group type: COMPARATOR
Intervention: 0.9% sodium chloride
Number of subjects: 432
Study: 34706654

Group type: EXPERIMENTAL
Intervention: Phantom exercises
Number of subjects: 24

Group type: COMPARATOR
Intervention: Mirror therapy and conventional physical therapy
Number of subjects: 24
Study: 32899926

Group type: EXPERIMENTAL
Intervention: Eyes closed condition in pwPD
Number of subjects: 15

Group type: COMPARATOR
Intervention: Eyes closed condition in control group
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Eyes opened vs. eyes closed conditions in pwPD
Number of subjects: 15
Study: 34476847

Group type: EXPERIMENTAL
Intervention: Sleep loss
Number of subjects: 15

Group type: COMPARATOR
Intervention: 8.5-hr sleep window
Number of subjects: 15
Study: 33843329

Group type: EXPERIMENTAL
Intervention: 3D printed transfer trays
Number of subjects: 30

Group type: COMPARATOR
Intervention: PVS transfer trays
Number of subjects: 30
Study: 33485813

Group type: EXPERIMENTAL
Intervention: Home Visits (HVs) conducted by a pharmacist and pharmacy students
Number of subjects: 18

Group type: COMPARATOR
Intervention: Office Visits (OVs) where patients brought their medications into the office for review
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Post-HV survey results
Number of subjects: 18
Study: 32546477

Group type: EXPERIMENTAL
Intervention: Enhanced paramedic‐initiated stroke assessment pathway (PASTA pathway)
Number of subjects: 453
Study: 34476616

Group type: EXPERIMENTAL
Intervention: AgNPs alone
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: AgNPs and ICG activated with diode laser (AN/ICG/DL)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: AgNPs activated with 0.3 W Er: YAG laser (AN/PIPS)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: AgNPs activated with tapered gutta‐percha (AN/MDA)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: AgNPs activated with ultrasonic (AN/PUI)
Number of subjects: 59

Group type: COMPARATOR
Intervention: 2.5% sodium hypochlorite (Control)
Number of subjects: 59

Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 59
Study: 32469138

Group type: EXPERIMENTAL
Intervention: Influenza vaccination
Number of subjects: 1037
Study: 34384000

Group type: EXPERIMENTAL
Intervention: Dutasteride-Tamsulosin 0.5 mg/0.4 mg capsule formulation (Dakart®)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combodart® (reference drug)
Number of subjects: 0
Study: 34710658

Group type: EXPERIMENTAL
Intervention: DPCP with multi‐concentration patch test
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard protocol for immunotherapy
Number of subjects: 30
Study: 32105334

Group type: EXPERIMENTAL
Intervention: Standard care + nature-based rehabilitation
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 101
Study: 35279970

Group type: EXPERIMENTAL
Intervention: 20 mL of 0.25% ropivacaine with 0.5 μg/kg (1 mL) dexmedetomidine (Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 20 mL of 0.25% ropivacaine with 1 mL of normal saline (Group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group B (dexmedetomidine)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Group A (normal saline)
Number of subjects: 60
Study: 34704841

Group type: EXPERIMENTAL
Intervention: Nurse-led palliative care intervention
Number of subjects: 42

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 42
Study: 34324231

Group type: EXPERIMENTAL
Intervention: CUF + MUF
Number of subjects: 79
Study: 32485893

Group type: EXPERIMENTAL
Intervention: 3 g/day biolactis powder (BLP)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Non-BLP extension group
Number of subjects: 237
Study: 35270635

Group type: EXPERIMENTAL
Intervention: Guided Written Disclosure (GWD)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Active Control (AC)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Non-completers
Number of subjects: 196
Study: 33352723

Group type: EXPERIMENTAL
Intervention: Olaparib (PARPi)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Olaparib (PARPi) + ATR inhibitor AZD6738
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Olaparib (PARPi) + CHK1 inhibitor MK8776
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Olaparib (PARPi) + ATR inhibitor AZD6738 + CHK1 inhibitor MK8776
Number of subjects: 3
Study: 36052331

Group type: EXPERIMENTAL
Intervention: 3-month cycle of weekly virtual museum tours of the Montreal Museum of Fine Arts (MMFA)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 106
Study: 32473216

Group type: EXPERIMENTAL
Intervention: Instructor-led education
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Web-only education
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Blended education (web and instructor-led)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: All modalities
Number of subjects: 248
Study: 35997601

Group type: EXPERIMENTAL
Intervention: Compression therapy and education
Number of subjects: 84

Group type: COMPARATOR
Intervention: Education only (Control)
Number of subjects: 84
Study: 34444103

Group type: EXPERIMENTAL
Intervention: Warning message with thunderstorm
Number of subjects: 276

Group type: COMPARATOR
Intervention: No warning message
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Warning message without thunderstorm
Number of subjects: 276

Group type: COMPARATOR
Intervention: No warning message without thunderstorm
Number of subjects: 276
Study: 32297558

Group type: EXPERIMENTAL
Intervention: NB‐UVB phototherapy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined NB‐UVB phototherapy with methotrexate
Number of subjects: 60
Study: 33146110

Group type: EXPERIMENTAL
Intervention: Education through Listening (ETL)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standard social marketing only (Control)
Number of subjects: 12
Study: 33277100

Group type: EXPERIMENTAL
Intervention: Static ultrasound
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Dynamic ultrasound
Number of subjects: 88
Study: 34785082

Group type: EXPERIMENTAL
Intervention: Controlled mouthguard (MCM - jaw in centric relation)
Number of subjects: 22

Group type: COMPARATOR
Intervention: No mouthguard (CON)
Number of subjects: 22
Study: 32086237

Group type: EXPERIMENTAL
Intervention: 0.02% atropine eye drops
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: 0.01% atropine eye drops
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control (SV spectacles only)
Number of subjects: 400
Study: 33894918

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 340

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 340
Study: 33193807

Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) with cheat sheet and data augmentation
Number of subjects: 0
Study: 34841633

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 35

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 35
Study: 33984876

Group type: EXPERIMENTAL
Intervention: Inhalation of lavender aroma
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Inhalation of spring orange aroma
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo intervention (control group)
Number of subjects: 90
Study: 33125428

Group type: EXPERIMENTAL
Intervention: Calcium-containing phosphate binders (CCPBs)
Number of subjects: 4295

Group type: COMPARATOR
Intervention: No use of calcium-containing phosphate binders (nonusers)
Number of subjects: 4295
Study: 35525132

Group type: EXPERIMENTAL
Intervention: Individualized blood pressure targets (after group)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard care (before group)
Number of subjects: 62
Study: 33273255

Group type: EXPERIMENTAL
Intervention: Power training
Number of subjects: 22
Study: 32859608

Group type: EXPERIMENTAL
Intervention: ETN + MTX
Number of subjects: 81

Group type: COMPARATOR
Intervention: MTX strategy
Number of subjects: 81
Study: 34324138

Group type: EXPERIMENTAL
Intervention: Beauty care (BTC)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Control (without BTC)
Number of subjects: 269
Study: 33638954

Group type: EXPERIMENTAL
Intervention: EMDR therapy (4 sessions, 60 minutes each) plus standard treatment
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 24
Study: 35997979

Group type: EXPERIMENTAL
Intervention: Azithromycin (20 mg/kg)
Number of subjects: 4726

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4726
Study: 33880087

Group type: EXPERIMENTAL
Intervention: CoCr-BP-BES
Number of subjects: 1257

Group type: COMPARATOR
Intervention: SS-BP-BES
Number of subjects: 1257
Study: 32847923

Group type: EXPERIMENTAL
Intervention: Nebulised salbutamol (10 mg)
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: Insulin/glucose intravenous infusion (10 units of short-acting insulin in an intravenous bolus with 500 mL of 10% glucose)
Number of subjects: 525

Group type: EXPERIMENTAL
Intervention: Combination of nebulised salbutamol and insulin/glucose intravenous infusion (10 units of short-acting insulin in an intravenous bolus with 500 mL of 10% glucose combined with 10 mg of nebulised salbutamol)
Number of subjects: 525
Study: 35560407

Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg/kg)
Number of subjects: 15
Study: 33836990

Group type: EXPERIMENTAL
Intervention: Intravitreal conbercept (IVC) 0.25 mg/0.025 mL
Number of subjects: 40
Study: 33045627

Group type: EXPERIMENTAL
Intervention: Percutaneous pulsed radiofrequency treatment of the dorsal root ganglia
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Percutaneous radiofrequency denervation of the medial dorsal branch
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (no radiofrequency treatment)
Number of subjects: 150
Study: 34369105

Group type: EXPERIMENTAL
Intervention: D+E (Diet and Exercise)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: D (Diet)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: E (Exercise)
Number of subjects: 94
Study: 33710631

Group type: EXPERIMENTAL
Intervention: Zinc deficiency prevalence in Asian population
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zinc deficiency prevalence in European population
Number of subjects: 0
Study: 32827209

Group type: EXPERIMENTAL
Intervention: Bupivacaine combined with ketorolac 15 mg/side for TAP block (TK group)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Bupivacaine for TAP block and 30 mg postoperative intravenous ketorolac (T group)
Number of subjects: 153

Group type: COMPARATOR
Intervention: 30 mg postoperative intravenous ketorolac alone (C group)
Number of subjects: 153
Study: 35722671

Group type: EXPERIMENTAL
Intervention: Mirror Effect Plus Protocol (MEPP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Basic counseling (Control)
Number of subjects: 40
Study: 32164142

Group type: COMPARATOR
Intervention: Post-marketing vaccines (specific types mentioned: influenza, rotavirus, cholera, pneumonia, EV71)
Number of subjects: 0
Study: 35101969

Group type: EXPERIMENTAL
Intervention: High-fidelity simulator (HFS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard low-fidelity simulator (LFS)
Number of subjects: 40
Study: 33316867

Group type: EXPERIMENTAL
Intervention: Physiotherapist-led exercise programme, approximately six contact sessions over a 12-week period.
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group not explicitly mentioned in the abstract.
Number of subjects: 76
Study: 35748449

Group type: EXPERIMENTAL
Intervention: Dual-cure adhesive resin
Number of subjects: 51

Group type: COMPARATOR
Intervention: Light-cure adhesive resin
Number of subjects: 51
Study: 35252108

Group type: EXPERIMENTAL
Intervention: TEaM Intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 36124638

Group type: EXPERIMENTAL
Intervention: Dostarlimab
Number of subjects: 325

Group type: COMPARATOR
Intervention: Doxorubicin
Number of subjects: 325
Study: 36227641

Group type: EXPERIMENTAL
Intervention: Tele-education via direct phone calls and text messages for 4 weeks
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no tele-education)
Number of subjects: 56
Study: 32835687

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 96

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 96
Study: 32223100

Group type: EXPERIMENTAL
Intervention: Sildenafil regular (50 mg qd)
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Sildenafil on-demand (100 mg 30 minutes before intercourse)
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Tadalafil regular (10 mg qd)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 334
Study: 35012696

Group type: EXPERIMENTAL
Intervention: Cariprazine
Number of subjects: 874
Study: 33973687

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP) therapy
Number of subjects: 57

Group type: COMPARATOR
Intervention: No therapy (control group)
Number of subjects: 57
Study: 34920291

Group type: EXPERIMENTAL
Intervention: Gatipotuzumab (500 mg followed by 1700 mg 1 week later) every 3 weeks until tumor progression or unacceptable toxicity
Number of subjects: 216

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Gatipotuzumab
Number of subjects: 216
Study: 32885343

Group type: EXPERIMENTAL
Intervention: Racial/ethnic discrimination writing task
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Academic/job-related failure writing task
Number of subjects: 34
Study: 33070271

Group type: EXPERIMENTAL
Intervention: Medial rectus plication
Number of subjects: 52

Group type: COMPARATOR
Intervention: Medial rectus resection
Number of subjects: 52
Study: 32000803

Group type: EXPERIMENTAL
Intervention: Blastocyst stage embryo transfer
Number of subjects: 658

Group type: COMPARATOR
Intervention: Cleavage stage embryo transfer
Number of subjects: 658
Study: 36396522

Group type: EXPERIMENTAL
Intervention: Colchicine 1.5 mg/day
Number of subjects: 227

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 227
Study: 35963181

Group type: EXPERIMENTAL
Intervention: CT + Memory Support (n = 91)
Number of subjects: 178

Group type: COMPARATOR
Intervention: CT‐as‐usual (n = 87)
Number of subjects: 178
Study: 32187168

Group type: EXPERIMENTAL
Intervention: Transactional sex
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Transactional sex among gay-identified BMSM
Number of subjects: 416

Group type: COMPARATOR
Intervention: No transactional sex
Number of subjects: 416
Study: 36240638

Group type: EXPERIMENTAL
Intervention: Probiotics (1 g/kg and 2 g/kg)
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Diet acidifier (2 g/kg and 3 g/kg)
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Combination of probiotics and acidifier
Number of subjects: 540
Study: 32949760

Group type: EXPERIMENTAL
Intervention: Air Barrier System (ABS)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control
Number of subjects: 43
Study: 32138775

Group type: EXPERIMENTAL
Intervention: Current traffic light label
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Current traffic light label with brochure
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Physical activity calorie equivalent label
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Physical activity calorie equivalent label with brochure
Number of subjects: 500

Group type: COMPARATOR
Intervention: Without nutrition label
Number of subjects: 500
Study: 35262226

Group type: COMPARATOR
Intervention: Individual learning (1 participant)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Dyad learning (2 participants)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Triad learning (3 participants)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Tetrad learning (4 participants)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: All groups (1 to 4 participants)
Number of subjects: 101
Study: 32369546

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg or 25 mg
Number of subjects: 7020

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 7020
Study: 34297721

Group type: EXPERIMENTAL
Intervention: Three-spike insole (TSI)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Total contact insole (TCI)
Number of subjects: 28
Study: 33148995

Group type: EXPERIMENTAL
Intervention: HIV status non-disclosure to partners
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Relationship duration <1 year
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Being in a polygamous relationship
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Unmarried status
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Uncertainty about partner's HIV testing history
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Lack of social support from people aware of their status
Number of subjects: 500
Study: 616623003

Group type: EXPERIMENTAL
Intervention: Score >=3 (intervention group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Score <3 (control group)
Number of subjects: 100
Study: 33663739

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 1767

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1767
Study: 32508213

Group type: EXPERIMENTAL
Intervention: Stimulant medication (methylphenidate)
Number of subjects: 113
Study: 33327336

Group type: EXPERIMENTAL
Intervention: Self-care education program
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 36178242

Group type: EXPERIMENTAL
Intervention: Structured health education
Number of subjects: 647

Group type: COMPARATOR
Intervention: Control group (no structured health education)
Number of subjects: 647
Study: 34156097

Group type: EXPERIMENTAL
Intervention: Topical epinephrine 1:1,000
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Topical epinephrine 1:10,000
Number of subjects: 30
Study: 32444901

Group type: EXPERIMENTAL
Intervention: Theory-based safer sex maintenance text messages over a 24-month period
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Theory-based safer sex maintenance text messages
Number of subjects: 602

Group type: COMPARATOR
Intervention: Counseling and texts on maintaining general health
Number of subjects: 602
Study: 36029704

Group type: EXPERIMENTAL
Intervention: Remimazolam
Number of subjects: 140

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 140
Study: 33548002

Group type: EXPERIMENTAL
Intervention: One SD increase in TSH
Number of subjects: 54288

Group type: EXPERIMENTAL
Intervention: Genetic predisposition to hypothyroidism
Number of subjects: 54288

Group type: EXPERIMENTAL
Intervention: Genetic predisposition to hyperthyroidism
Number of subjects: 54288

Group type: EXPERIMENTAL
Intervention: GRS for fT4
Number of subjects: 54288

Group type: EXPERIMENTAL
Intervention: GRS for TSH and hypothyroidism
Number of subjects: 54288

Group type: EXPERIMENTAL
Intervention: GRS for hyperthyroidism
Number of subjects: 54288

Group type: EXPERIMENTAL
Intervention: Genetically predicted thyroid function
Number of subjects: 54288
Study: 35593928

Group type: EXPERIMENTAL
Intervention: Bony wall group (BW) - repositioned bony wall after piezosurgery
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Collagen membrane group (CM) - collagen membrane coverage after rotary instrument preparation
Number of subjects: 40
Study: 33596017

Group type: EXPERIMENTAL
Intervention: Personalized glaucoma education and coaching
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard education
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MI-SIGHT Program
Number of subjects: 0
Study: 33093297

Group type: EXPERIMENTAL
Intervention: Informational video for patients regarding antibiotics in diverticulitis
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Evidence summaries for physicians regarding antibiotics in diverticulitis
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Non-antibiotic strategy
Number of subjects: 50
Study: 35126605

Group type: EXPERIMENTAL
Intervention: Yushen Tongluo Granule (YSTLG) combined with Clomiphene Citrate (CC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (YSTLG placebo)
Number of subjects: 0
Study: 32143061

Group type: EXPERIMENTAL
Intervention: Text-message based home blood pressure monitoring system
Number of subjects: 84
Study: 35305674

Group type: EXPERIMENTAL
Intervention: NU-HOME intervention (n = 58)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control group (n = 56)
Number of subjects: 114
Study: 32012056

Group type: EXPERIMENTAL
Intervention: Lock to Live (L2L) decision aid
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (website with general suicide prevention information)
Number of subjects: 49
Study: 36302128

Group type: EXPERIMENTAL
Intervention: Outpatient THA
Number of subjects: 115

Group type: COMPARATOR
Intervention: Inpatient THA
Number of subjects: 115
Study: 32794131

Group type: EXPERIMENTAL
Intervention: L-carnitine
Number of subjects: 2

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 2